| Carcinogenicity information is currently unavailable.
Due to the nature of glatiramer acetate's immunomodulating nature,
there is a theoretical risk it may interfere with the recognition of
foreign antigens in a way that would undermine the body's tumor surveillance
mechanisms.
|
